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The three betrayals of the medical cannabis growing activist: from 




While cannabis has been widely used in the UK for over 50 years, it is only in 
recent decades that domestic cultivation has become established. Public 
concern, media reporting and policing policy has emphasised the role of profit 
motivated criminal organisations often working on a large scale and with 
coerced labour. However, increasingly, another population are growing for 
medical reasons, to help themselves and others treat or manage difficult, 
poorly understood, or incurable conditions. 
Our study sought to further understand the motives, techniques and 
interactions of cannabis cultivators through interviews with 48 growers and 
supplementary ethnographic work. As well as those motivated to grow for 
personal use, social and commercial supply purposes we identified a cohort 
growing to provide themselves and others with cannabis used for therapeutic 
purposes. This paper draws primarily on interviews with a sub-group of 
sixteen medically-motivated growers who were not only involved in treatment, 
but also embraced the label “activist”.  
Rather than develop techniques of deception they were organising to effect a 
change in legislation. Rejecting the image of criminal perpetrators, they 
presented themselves as victims of unjust government policy, an indifferent 
medical establishment, and brutal and immoral criminal markets. Through 
cultivation, association, self-healing and apomedication, they have found 
voice and are shifting the debate over the status of growers and of cannabis 
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itself. The ambiguity of their position as both producers and patients 
challenges the assumptions underlying legal distinctions between suppliers 
and users, with potentially profound implications for policy. 
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apomedication, drug policy reform 
  




Cannabis continues to enjoy an ambiguous status in the UK. It is a Class B drug 
with strict penalties for possession and supply, but consumption is not a crime 
per se1 and police rarely bring charges and do not go proactively looking for 
people in possession of small amounts2. Prominent anti-cannabis campaigners 
have cited the falling number of cannabis arrests in their claim that to all intents 
and purposes cannabis consumption has been decriminalised (Hitchens, 2012). 
The numbers are indeed low considering that 16% of 16-24 year olds are 
reportedly using cannabis (Home Office, 2016). However, there remains a 
significant rump of cannabis users who do face sanctions, and criminal records, 
for production and supply. 
 
The UK, as other European countries, subscribes to a “balanced approach” 
(Home Office, 2015), making a sharp distinction between consumption, with its 
associated potential health and socioeconomic harms, and supply, dealt with by 
the police and courts. This has allowed the state to maintain an uncompromising 
prohibitionist policy stance even while consumption is becoming socially 
embedded with stable drug prices and ready availability. Import substitution 
continues apace, with cannabis resin from Morocco largely replaced by 
                                                        
1 Possession and supply are offences under the UK’s Misuse of Drugs Act, 1971, but drug 
use is not. 
2 Policy varies by police force in the UK, but a general relaxation of enforcement of cannabis 
laws has been widely reported. See, e.g., Staufenberg (2015); Dunn (2016).    
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domestically produced herbal cannabis (Potter, 2010; Hargreaves & Smith, 
2015).   
 
It has been estimated that around 300,000 – 500,000 people are now growing 
cannabis in the UK.3 Cultivation ties up financial resources, encroaches on indoor 
living space, greatly increases the risk of detection and facilitates the prosecution 
with incontrovertible material evidence as well as demonstrating mens rea. The 
question therefore arises why so many people are willing to risk criminalisation 
by amplifying their offence from cannabis possession to cultivation and supply.  
The paper explores the motivation of a sub-set of cannabis cultivators who use 
cannabis therapeutically, or supply cannabis to people with medical conditions 




We were awarded a small grant from the British Academy/Leverhulme Trust4 to 
study cannabis cultivation in the UK, with a focus on initiation into and 
progression of cannabis growing careers.  We opted for an inductive, 
ethnographic approach in the anthropological tradition, with in-depth 
qualitative interviews and observations of real life situations, as best suited for 
establishing an understanding of motivation and outlook. From previous work 
we hypothesized that financial benefits and the quest for quality product were 
                                                        
3 The figure was repeated by several activists, and seems to be based on a calculation by the 
Independent Drugs Monitoring Unit reported in the Daily Mail (Hall and Camber, 2014) 
extrapolated from the number of cannabis farms “discovered” per month. 
4 Small grant reference SG132364. 
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the main drivers for cultivation (Decorte, 2010; Potter, 2010; Potter et al., 2015; 
Weisheit, 1992), with easier access to growing technologies (via grow-shops and 
online retailers) and knowledge, information and advice (via cannabis websites 
and discussion forums) being key enablers for those who are so motivated 
(Potter, 2008; 2010; Bouchard, Potter & Decorte, 2011). Recognising the role of 
online forums in cannabis cultivation, and following the practice of other 
research projects (Decorte, 2010; Barratt et al, 2015), we posted notices on 
websites and online forums for cannabis enthusiasts, growers and activists 
asking people to share their stories. This meant that people contacted us if they 
wanted to be interviewed and were therefore a self-selecting cohort including a 
significant sub-sample of user-grower activists. In addition, we mobilised 
personal networks and onward referrals. In total, we conducted interviews with 
48 cannabis growers, supplemented with many more informal conversations 
and online interactions. This paper draws primarily on a sub-sample of sixteen 
respondents, as explained below. 
 
Where possible we visited growers at their homes and cultivation sites, 
observing informants with their plants and in their own environment. In other 
instances, interviews were conducted in pubs or cafes where respondents felt 
comfortable to talk. Interviews lasted between one and four hours and followed 
a semi-structured schedule of questions on key topics, including medical use and 
activism. In most cases, there was also much free flowing conversation, which 
created a more relaxed atmosphere and allowed informants to drive the agenda 
and take ownership of the information they were sharing with the researchers. 
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On a number of occasions we conducted repeat interviews, at the suggestion of 
informants, to dig deeper into particular issues.  
 
To observe interactions between cannabis cultivators, their exchanges of 
information on growing techniques, the preparations of medicine, and political 
organisation, we also attended meetings organised by cannabis activists in 
Kirkby Lonsdale (England) and Dublin (Ireland), and visited a commercial illegal 
cannabis coffeeshop in London.  Most pertinently, we were able to attend the 
2016 Annual General Meeting of the United Kingdom Cannabis Social Clubs 
(UKCSC) in Leicester. Participation at these events allowed us to cross-verify that 
issues raised during interviews were widespread, and distinguish between 
different positions and viewpoints. 
 
Where feasible, and when granted permission to do so, interviews were 
recorded. In other instances, contemporaneous notes were taken. Further notes 
were written up after the interview or event. We worked to the ethical standards 
of the British Society of Criminology and Lancaster University5 – data was 
securely stored, and the anonymity of all respondents maintained even though 
many (in keeping with their activist personas) stated that they did not mind 
being identified. 
 
Pursuing a grounded theory approach (Glaser & Strauss, 1967), our theoretical 
model emerged through the repeat analysis of data. The sample comprised 
                                                        
5 Ethical clearance was granted by Lancaster University Faculty of Arts and Social Sciences 
research ethics committee, ref. FL16005. 
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cultivators growing for their personal use, those supplying friends and family 
(i.e., social supply) and those involved in commercial distribution. But one cohort 
vehemently denied any sense of criminality and rejected the charge of cannabis 
use as a hedonistic indulgence. Instead, they were growing cannabis for health 
reasons, to self-treat an illness or condition and/or to supply fellow patients. It is 
this subset of growers that we discuss in this article. 
 
In response to the allegation that medical benefits serve as a pretext for 
recreational use (Wilkinson & d’Souza, 2014), we note that the drawing of such 
neat distinctions between medical and non-medical use was one thing that 
informants had set out to challenge. While several discussed specific, diagnosed 
conditions others claimed benefits for no particular illness, but a more general 
sense of well-being, often with a spiritual dimension. One informant reported 
that she only realised how much she had needed cannabis when she stopped 
using temporarily and then began to experience symptoms of both physical 
health problems stemming from a car crash and mental health problems relating 
to traumatic childhood experiences. The category of ‘medical cannabis user’ is 
therefore slippery (cf. Reinarman et al, 2011), as is that of ‘medical cannabis 
grower’ (Hakkarainen et al., in press). As such, attempts to clearly delineate 
between medical and non-medical growers among our respondents would be 
artificial. Instead, this article draws primarily on sixteen informants who were 
growing primarily to treat diagnosed conditions in themselves or others and 
who embraced the label “activist”, but informed also by other data generated by 
our ethnographic approach. To emphasise the “ideal-type” medical growers at 
the core of this paper, we should note that several were also seeking to moderate 
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THC strength and experimenting with preparations that had minimal 
psychoactive effects while still providing therapeutic relief.  
 
 
Victimless crimes reconsidered – medical cultivators as anomalies in the 
drug war dramaturgy 
 
By cultivating cannabis and sharing the product with other users our informants 
had moved from petty offender to criminal perpetrator of a class B supply 
offence, which carries potentially up to 14 years imprisonment. Craig opened 
with the familiar assertion of the victimless crime: “if I am not hurting anyone 
what is that crime”. He then turned the more serious charge of drug production 
around, arguing that he was in fact helping to reduce overall criminality: “I am 
not contributing to a criminal market. I am not impacting negatively on anyone 
other than me.”  
 
It would be possible to explain such defensive statements in terms of 
neutralisation theory (Sykes & Matza, 1957), on the assumption that cultivators 
were seeking to reconcile their criminal behaviour with a conditioned urge to 
abide by moral and legal codes. Indeed, many informants underlined their pro-
social values and integration into wider community structures. Sam and Mary 
emphasised the contribution they had made in the course of their professional 
lives as law-abiding, tax-paying, family-raising citizens, and Brendan, in a 
pointed comparison with members of the political elite, said he was paying tax 
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on all inputs into his grow operation and even the income from selling his 
surplus cannabis.   
 
None of these objections sways prohibition advocates who regard drug use as 
immoral and deserving of punishment (Husak, 2002:109-119; Sullivan & 
Austriaco, 2016). In justification of such punitive paternalism, prohibition 
advocates argue that the “majority who would use responsibly ought to be 
willing to give up their fun to protect the minority who would not…” since “in a 
free society there are plenty of other ways to have fun.” (Caulkins, 2012:239 f).  
 
Drug users have no legally enshrined right to intoxication, but carry instead the 
stigma of an illegitimate and immoral activity, and with the spread of drug 
testing technology, need increasingly to demonstrate their abstinence.6 The drug 
war, in both its dramaturgy and its schematics, has therefore divided the 
population into users/non users (default position), with the first group 
potentially subject to the control of the criminal justice system but divided into 
separate roles with different degrees of moral culpability each triggering a 
different kind of intervention:  the criminal supplier / hedonist consumer / 
addict.  
 
Medical cannabis cultivators fall outside the scheme. They are drug producers 
and suppliers, whose own use resembles the hedonist in terms of control and 
deliberation, but the addict in frequency and dependence.  Yet their motivation 
                                                        
6 Although more established in the US, drug testing is on the rise in Europe in a number of 
contexts (Paul & Egbert, 2016). Workplace drug-testing in the UK increased significantly 
between 2011 and 2014 (Ironmonger, 2014). 
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and the context of their use disrupts the frame altogether, as they grow not for 
profit but for necessity, use not for high but for health, and present themselves as 
patients not criminals. As Potter has noted previously (2010), these people are 
driven by need, not greed. 
 
Inadvertent cultivators  
 
Cultivators often presented their lives as journeys beginning with the life-
changing illness and a series of cumulative events, such as the discovery of 
cannabis, quests for greater knowledge, encounters with significant teachers, 
and the decision to start growing. The stories contain elements of what the 
anthropologist Victor Turner (1969) describes as the ritual progress and, 
subsequently, the idea of social drama. Individuals experiencing a crisis that 
breaches the common norm are pushed outside of the conventional frame, with 
the sudden dissolution of structure, identity and social action. This was the 
diagnosis itself, which was in the case of Craig, “a life sentence”. Mary also 
reports a sense of helplessness when learning at 32 that she had MS, until a 
friend told her about the medical benefits of cannabis. She was grateful she had 
smoked it recreationally, because she felt able to travel to Amsterdam and 
acquire the technique and basic inputs for growing.  
 
Using cannabis in a purposeful, systematic way, followed by the decision to grow, 
are ways in which informants report regaining control over their lives from the 
disease, a process Turner (1969) captures as “redressive action”. When Howard 
learnt he had Crohn’s disease and would “soon have my guts removed and be fed 
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through a straw” he says he took a one-way ticket to Colorado where he met 
“Ganja John”, a man with only one functioning kidney who taught him how to 
grow cannabis and use it medicinally. Now he is back in the UK in excellent 
health, growing his own crop and sharing his skills with others.  
 
Receiving and sharing are recurrent elements in the narrative of medical 
cannabis growers, woven into a sense of communitas by all facing debilitating 
and possibly incurable conditions, and the shared status of the outlaw, liable at 
any moment to be raided, arrested and deprived of liberty. The decision to take 
such steps is difficult, like any rite of passage, and aided, necessarily by 
inspirational figures like the expert grower Jeff Ditchfield, whose cannabis café 
“Beggars Belief” in Rhyll, North Wales, is a cause celebre in medical cannabis 
circles.7 
 
Jane was left with spinal injuries and Complex Regional Pains Syndrome after a 
car accident at 29. She found that smoking “half a spliff after the children had 
gone to bed eased the pain”, and that different strains and types of cannabis 
acted differently. She read up about it, then learnt from Jeff Ditchfield before 
producing her oils.  But in addition to the technical advice she also had 
encouragement to articulate her resentment at the structural discrimination. “I 
want to see it legalised and feel angry that it isn’t.” She thinks that cannabis 
                                                        
7  The café provided space where patients met with growers to exchange hints, tips and 
medicines in a friendly environment. The café was raided on several occasions and Jeff 
Ditchfield taken to court. The jury always ruled in his favour, convinced by the defence that he 
was donating medicine https://jeffditchfield.wordpress.com/beggars-belief/ 
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should be regulated under the principle of consumer rights and that only vested 
interests of the pharmaceutical and alcohol industries are holding it back.  
 
Three betrayals  
Already let down by their bodies, our activist medical growers identified three 
other ways in which they felt betrayed: by the legal system that labels them as 
criminals, by conventional medicine that cannot help them, and by criminal 
operatives in the illegal cannabis market. 
 
Criminal justice authorities 
 
As a responsible citizen, Jane feels angry at the way she was treated during a 
police raid in the past, “a horrible violation”, and more recently the harassment 
by a police community support officer (PCSO), “a hobby bobby”, possibly alerted 
by a hostile neighbour.  On one occasion he entered her garden unlawfully, 
confiscated some cannabis and issued her with a caution, dismissing her claim 
that this was her medicine.8 Angered by his attitude Jane reported the incident to 
the police complaints commission and learnt from a sympathetic duty sergeant, 
who told her “you are not a criminal”, that the cannabis had not been handed in.  
 
Informants remain perplexed by police motivation. Sally, who suffers from 
Crohn’s disease, begged the officers who raided her house not to take her 
medicine. “One of the officers gave me hug and said don’t worry love, it will soon 
                                                        
8 PCSOs do not have the powers to enter premises.  
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be legal for people like you.” But they held her for seven hours at the station even 
though she was feeling weak and walking on crutches. 
 
The worst thing is the continuous sense of fear. Craig says it does not matter to 
him, but his partner worries and wakes up in the night. Several informants use 
the term paranoia and discuss their strained relationship with the law. Mary 
describes her anxiety as a mild case of PTSD and remembers the panic one night 
when hearing a knock and seeing the silhouettes of two police officers through 
the door. It turned out that the officers were interviewing people following a 
break-in in the neighbourhood. But not knowing that, Mary and her husband had 
rushed to close the grow room and put everything in the attic. “People who are ill 
don’t need that kind of worry”. While she believes that most policemen do not 
want to arrest sick people there are always some who want to “make up 
numbers”. 
 
The cumulative effect of these experiences is that, “people are fed up of the so-
called government that is being the servant of the people turning around to say 
that cannabis has no health benefits and make it illegal” [Doug]. 
 
Conventional medicine 
Another target for criticism was what several informants described as 
‘conventional medicine’, which had been unable to cure or even properly 
understand their conditions. There were, furthermore, incidents of misdiagnosis, 
inappropriate treatment, and even failed surgical interventions. Sally recalls 
surgeons apologising to her “after one botched operation” and blames the 
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morphine prescription for triggering her stomach spasms and leaving her with 
withdrawal symptoms.  
 
Not only were medical practitioners unable to help, but often they were very 
negative about cannabis use. Justin, who suffers from bipolar disorder and 
extreme anxiety, was told that he would only be referred to a psychotherapist if 
he stopped using. Confirming trends reported elsewhere in Europe 
(Hakkarainen et al., 2015; Grotenhermen  & Schnelle, 2003), UK medical 
cannabis users are reluctant to confide in their doctors. According to one online 
survey, a third of the 623 respondents refused to disclose with another quarter 
reporting a hostile response.9 
 
Medical practitioners only echo the negative assessment of cannabis, which was 
removed from the British pharmacopoeia in 1932. Several decades later it was 
placed in schedule 110 of the classificatory system created by the 1971 Misuse of 
Drugs Act under advisement from the medical associations. Today the main 
professional bodies, the British Medical Association and the Royal 
Pharmaceutical Society, remain unconvinced of its therapeutic properties 
despite the current state of knowledge (Barnes & Barnes, 2016). Even the large 
medical charities such as Cancer Research are sceptical: “At the moment, there 
simply isn’t enough evidence to prove that cannabinoids – whether natural or 
                                                        
9 The United Patients Alliance conducted a survey of (self-identified) medical cannabis users 
in the UK in 2016. The 25-question survey was distributed through social media. 623 were 
returned valid, reporting cannabis use in connection with a range of conditions, including 
depression (30%), Anxiety (26%), chronic and severe pain (24.1%), Arthritis (12%), Insomnia 
(21%), fibromyalgia (9%), PTSD (7%). The report was submitted to the All-Party 
Parliamentary Group for Drug Policy Reform. Courtesy of John Liebling. 
10 Reserved for substances that have no recognised medical benefit. 
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synthetic – work to treat cancer in patients, although research is ongoing. And 
there’s certainly no evidence that ‘street’ cannabis can treat cancer”.11  
 
This reluctance by medical authorities to endorse the therapeutic value of 
cannabis leaves cannabis-using patients feeling isolated and abandoned. Sally 
says “there is nothing that conventional medicine can do for me” and relies 
entirely on her own herbal products. Mary, too, puts her faith in a combination of 




Yet cannabis is not always easy to come by at the best of time, particularly when 
people are physically impaired. Before they started self-supplying, medical users 
were dependent on an often-unsympathetic criminal market. Charlie, who 
suffers from rheumatoid arthritis and walks with the aid of crutches, says “You’d 
think they would respect someone with a disability, but no. These young guys 
just took my money and ran off.” Others report sending their partners to 
purchase cannabis for them, but without the social capital to operate in criminal 
drug markets they were taken advantage of and cheated.  
 
Because the industry is not regulated properly opportunities arise for fraudsters 
and charlatans.  Jane refers to a cannabis grower who was widely reported in the 
media claiming to have cured his cancer with cannabis. Since then a “foundation” 
                                                        
11 http://scienceblog.cancerresearchuk.org/2012/07/25/cannabis-cannabinoids-and-cancer-
the-evidence-so-far/#campaign 
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has been named after him charging £300 per consultation and then £100-200 for 
a 1 ml syringe of cannabis oil. 
 
For her, it is one more manifestation of systemic problems, because “prohibition 
opens opportunities for scammers”. She has bought oil that turned out to contain 
only minimal amounts of THC and CBD, with “a medicinal profile similar to olive 
oil. Some people sell the product from commercial weed trimmings that is not 
even flushed properly with isopropyl alcohol.” These are substandard products 
produced without care and pride simply for profit.  
 
 
Reconstituting selfhood  
 
The situation, as seen by our respondents, can be easily summarised. People with 
a medical need for cannabis but criminalised by government, denounced by their 
doctors and cheated in the underground markets, find themselves the victim of 
successive betrayals. Their rupture with prevailing norms is no wilful pursuit of 
egotistical or hedonistic ends, but an act of self-preservation. The resulting 
anomie, in the Durkheimian (1893) sense of “derangement” as a mismatch of 
standards between the group and the wider society, results from a tension in the 
social contract that guarantees a right to healthcare, but excludes the cannabis 
patient. 
 
This situation mirrors the drug users of Merton’s (1938) classic social strain 
theory, who, prevented by their own circumstances from realising society’s 
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values, retreat into an inner world. Only the medical cannabis user is no failing 
individual. Instead, society and its normative frame are failing her.  
 
The turn to cannabis production, far from comprising a defeatist retreat, is a 
positive assertion of agency, with the cultivator assuming control over her/his 
therapeutic regime. It means adjusting to the possibility of arrest and prosecution 
and redefining the status of and relationship with cannabis.  
 
Committing to cannabis 
 
Medical users therefore emerge from the closet and integrate cannabis into their 
identity. Jane, recounting her troubles with law enforcement and informers, 
shrugs and says “I am a proud cannabis smoker, but it was a long journey”.  
 
Most medical cannabis growers manage their communications and interpersonal 
relations carefully, particularly with those whom they allow into their private 
space. Often negotiation is required, as in the case of Mary, whose cleaner, once 
opposed to drugs, now takes cannabis balms for her own mother. She believes 
that people in the village know about her use by now.  
 
James has even informed his local police that he is growing cannabis. Should he 
ever get raided he will ask “why now, you have known about this for 2 years?” 
Craig, who is friends with police officers, says he is open about his cannabis use 
as it is important to establish a public identity as a cannabis user.  
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One unlikely setting is the local government council. Den is a busy member of the 
community involved in committee work and helping organise local activities. At 
one council meeting about public safety and the problems caused by drinking he 
brought the discussion to cannabis and how safe and pro-social it was. He 
remembers feeling “fucking proud of myself when I walked out of that meeting.”  
 
The experience of “coming out” publicly as cannabis users is liberating and self-
affirming. It means being accepted for what is seen as an important part of 




Winning over family 
 
 
Sally depended through some of the most critical periods of her illness on her 
mother who has never taken cannabis herself, but says “I could see what pain Sally 
was in and thought if it works, why not.” Jane’s dad also proved acquiescent when 
he observed the results. Over the years she managed to turn a “rabid 
prohibitionist” into a cannabis advocate, who now applies a balm she makes to his 
own skin.  
 
For many users there are stories of conversion, critical Damascene experiences 
where a sceptical significant other is won around. Howard convinced his mum by 
curing the dog. The family pet was advanced in years, very ill, foaming at the 
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mouth despite the vet’s best efforts. Then Howard fed him a few cannabis laced 
cupcakes and affected remission. Now both his parents fully support not only his 
use, but also his cultivation and political activism.  
 
In situations of co-habitation, acceptance and support from parents or partners is 
a precondition for any cultivation.  This invariably involves risks, as parents may 
withdraw support and estranged and vengeful partners can inform the 
authorities. But beyond the practical aspects of being given license to grow and 





For people with serious health conditions another important relationship is with 
their healthcare providers. While the majority of informants in the 
aforementioned survey avoided the topic of cannabis, or had a negative or neutral 
response, a significant number (40%) of doctors were supportive (cf. Sznitman, 
2017).  It would appear that there is far less consensus about the therapeutic value 
of cannabis among medical professionals than the resolute scepticism of the 
professional bodies would suggest. Den remembers being referred to “Professor 
X”, a respected specialist in his condition working at a major UK teaching hospital, 
who confirmed that “cannabis was the best medication for my pain which was 
what I must have subliminally known because I had been smoking more and 
more.” But sympathetic medical professionals are rarely well informed and often 
unsure about cannabis preparations.  
  21 
 
This is where Jane had to step in. “I had to educate my doctor who now advises 
every patient presenting with Complex Regional Pains Syndrome to use cannabis.” 
Going even further, he has prescribed her with Sativex, not to use it but as a cover 
in case she is ever drug-tested. Mary’s doctor also came to accept cannabis when 
he observed her health improve. She gave him a medical cannabis textbook and 
says “I have normalised it in my doctor’s surgery”. The willingness of medical 
professionals to accept the expertise of users compares favourably with an earlier 
Norwegian study (Pederson & Sandberg, 2013). But convincing a medical 
professional requires social capital. Not all medical cannabis cultivators have the 
professional status and educational attainment to lend credibility to their claims 
in discussions with medical practitioners. Yet this does not mean they have no 




Medical cannabis healers and apomedication 
 
Doug, who works cannabis butter into a poultice that he applies to his injured 
rotary cuff, is proud to share his homemade medication. Discussing the 
dissemination of therapeutic expertise on cannabis in Canada, Penn (2014) noted 
the critical role of dispensaries organised into the Canadian Association of Medical 
Cannabis Dispensaries (CAMCD) in forming an “embodied health movement”. Less 
formally in the UK, individuals, small-scale producers such as the CBD brothers 
and loose, unrecognised cannabis clubs exchange information via social media and 
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at organised events.  They discuss cannabis strains, preparations, growing 
techniques and medical applications. Since medical authorities have vacated this 
space, Doug feels entitled and even morally obligated to move in to help others.  
 
They build on the prior challenges to traditional hierarchies where medical 
professionals are omniscient and the patient a passive object of care. In the long-
term care of chronic conditions, patients become recognised as experts and 
partners so that “self-management, within the boundaries of a medical regime, 
becomes a real option” (DoH, 2012). Pushing well beyond those boundaries, 
medical cannabis growers can replace the clinician by providing patients with 
similar diagnoses with treatment options and prognosis on disease progression.  
 
Crucially, however, they do so outside of conventional knowledge hierarchies, as 
their expertise draws from a convergence of embodied health experience with 
knowledge filtering in a situation of information abundance.  The apomediary 
can guide towards information sources and services but has no power over their 
provision or the decision making process itself (Eysenbach, 2008).  Both Sally 
and Doug give detailed advice to people with similar gastrointestinal disorders 
and Mary counsels other MS sufferers. Potentially, such therapeutic relationships 
can turn into joint journeys of discovery, with both (or more) parties exchanging 
information as equal partners in the healing process.  
 
Much occurs through Facebook and Instagram pages, in small groups or on a 
one-to-one basis.  Since advice is often complemented by medicines and a 
combination of seeds, cuttings and knowhow, the process is better described as 
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apomedication. At the frontier of medical knowledge, a space has opened where 
the medical cannabis patient/grower becomes a medical authority. Particularly 
in the case of rare conditions, advice and remedy are passed from patient to 
patient, who take ownership of their condition and gain experience that can be 




The most important transferrable skills are horticultural, hence social media is 
abuzz with information on seedlings, plants, lighting, plant feeds, soil consistency, 
harvesting and drying. There are multiple motivations. Den says he “helped set up 
one guy” after “feeling guilty” about the money he was taking off him. For Brendan 
“helping people to become independent growers of quality cannabis is what I am 
about”, something like a personal vocation. Others cite a genuine evangelism 
rooted in the conviction that cannabis is a positive, health-giving force, or 
inspiration from foundational texts by Jeff Ditchfield or others.  
 
That push for social acceptability has raised confidence. Liam, who is in touch with 
over 200 growers in his area, states “the community aren’t scared anymore”.  
Finding safety in numbers after living with the fear of the knock on the door is 
both motivator and reward. Rachel remembers “sneakily smoking joints out of the 
attic.” She thinks that “in terms of rebellion, growing your own is one of the biggest 
forms of activism you can do because you’re actually challenging the system.” 
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The most comprehensive challenge is posed by the UKCSC whose “peaceful 
activism” aims at ending “prohibition and the unjust, unfair criminalisation of 
cannabis consumers”.12 Based on a model that first evolved in Spain (Decorte, 
2015; Belackova et al, 2016) the clubs are registered not-for-profit organisations 
that provide a platform for local cannabis collectives. There is a clear firewall 
between local groups involved in the actual growing and the UKCSC, who provide 
technical advice and register the plants. They refer to official sentencing 
guidelines when advising growers to keep the number of plants below 10 
(Sentencing Council, 2012).13 
 
The UKCSC go further than campaign groups like “End our Pain”14 or the United 
Patients Alliance, 15  by extending their demands to recreational and social 





The UKCSC regard themselves as a quality-control body that warns of sub-
standard suppliers while showcasing UK growers. “We have got a good quality 
and professional industry in this country who win cups in the US and want to feel 
                                                        
12https://www.smokersguide.com/adressen/12190/ukcsc_united_kingdom_cannabis_social_cl
ubs.html#.WPSMhrvyvow 
13 The guidance notes for drug offences advise sentencers to weigh up all factors when 
assessing culpability, including the output determined by the number of plants. A ‘lesser role 
of culpability’ is where the operation is ‘solely for own use’, and the lowest ‘category of harm’ 
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people pride in using their products. Why should they miss out on this when 
people in another country can do it and get a head start because the law is 
different?” [UKCSC spokesperson]. 
 
In the West Country, Jane is a member of the local cannabis collective associated 
to the UKCSC and has gotten together with some other women to form a group of 
“Lady Gardeners”. They want to meet the medical need for cannabis product that 
is different from the “pharma ganja” promoted by groups like ‘End our Pain’. 
There is also a rejection by female activists of the male-dominated illegal medical 
supply networks and exploitative relationships with customers/patients. She 
takes good care of her plants, is careful to use only organic inputs, and takes 
pride in process and product.  
 
Craft and pride in the product are a recurring theme. Some describe themselves 
as connoisseurs, and all have clear preferences about strains and the particular 
effects they want. Coupled to that is a disgust for inferior weed, with frequent 
talk about adverse side effects from adulterants, chemical fertilizers or plant 
pests. Much – perhaps most – of the product traded on the criminal market is of 
inferior quality as the purveyors are driven by greed (cf. Potter, 2010) and 
allowed to operate by a government that is indifferent to the needs of medical 
cannabis users.  
 
 
Changing the frame 
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In our fieldwork, we met people moving from the minor offence of drug 
possession to the trafficking offences of production and supply solely to secure a 
regular source of quality medicine to manage difficult conditions. They had been 
pushed towards cultivation by governments that, with support from the medical 
professions, had prohibited cannabis, and the failure of the criminal market. 
Many informants presented themselves as responsible people, who held down 
jobs, paid taxes, raised families and contributed to their communities. They saw 
themselves as multiple victims faced by a grim choice of breaking the law or 
bearing the pain, and had been pushed to re-define themselves as medical 
cannabis users, “expert by experience” healers, quality growers and activists.  
 
Far from seeing themselves as criminals, medical cannabis users project the 
image of multiple victimhood – of government inertia, medical incompetence and 
criminal conspiracy (as well as a victim of whatever medical conditions afflict 
them). It is not so much a question of being in breach of the law, as of the law 
being against them. Criminal convictions were rare among medical users, as was 
experimentation or use of other drugs (cf. Potter et al., 2015). Instead, they 
would emphasise their professional achievements, educational attainments and 
pro-social attitudes.  
 
One of the advantages of growing for themselves was an ample supply that 
allowed Jane, for instance, to “smoke pure” (i.e. not mixing cannabis with 
tobacco). Many do not smoke at all but use vaporisers. Hakkarainen (2016) has 
noted that the arrival of new delivery systems has allowed the cannabis user to 
rebrand themselves from “loser stoners” to “cool fashionistas”. However, it is not 
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a quest for “cool” that motivates the medical user but health concerns over the 
detrimental effect of smoking as a delivery system and the mixing with tobacco. 
Sally, amongst others, takes her cannabis only orally, either raw-juicing her 
cannabis plants or using the buds and trimmings to make “medibles” (medical 
edibles, like chocolates and biscuits). Indeed, Howard says that some “purists” 
are openly derogatory about smokers who mix their cannabis with tobacco.  
 
Cannabis by contrast is endowed with extraordinary positive attributes, and 
some people profess affection for and gratitude to their plants. Eddie is aware 
that he is sounding “like a fanatic” when extolling its virtues from medicine to 
food to construction material. “You can even build a car out of it, I love that 
plant.” He is not alone in using that phrase. Tony also has “a love relationship 
with the plant, I want to caress and talk to it. After smoking for over 25 years on 
a daily basis I am part cannabis, I have THC glands.” 
 
Like many gardeners, growers see character in their plants. According to Mary, 
cannabis has eccentricities that become manifest in the drug effect. She has a 
hybrid called “Fortune Teller” that “makes you think and smile and feel happy.” 
Personality and powerful psychoactive effect merely confirm the special status of 
cannabis. What really sets the plants apart, for many of the medical growers, is 
that they have healing powers. 
 
Den was undergoing surgery and under a severe regime of medication. “You 
know, I’m not claiming cannabis saved me, but if it weren’t for cannabis, I 
wouldn’t have been able to take the dosages of these drugs that they’d actually 
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have to give me to keep it under control.” Sally, Howard, Justin and Jane all 
attribute their health improvement to cannabis, while the MS patients Mary and 
Craig need it for their everyday functioning.  
 
The extravagant claims about cannabis as a cancer cure known from media 
stories or websites like “illegally healed”16 are echoed by informants who grow 
not to treat their own medical problems, but to divert some of their crop to help 
others. Liam first began producing oil when his brother was diagnosed with lung 
cancer. Since then he has “given it to a couple of people and they cured.”  
 
If the growing body of evidence for palliative care and pain management help 
transform the status of cannabis from “menace to medicine” (Waldstein, 2010), it 
is these spectacular achievements in “curing cancer” that imbue it with powers 
of non-human agency that challenge the underlying assumptions of drug policy. 
As Weinberg (2011) observes, social policy on drugs is predicated on the 
unusual powers of these substances that requires the state to protect people 
from themselves. 
 
Cannabis advocates pick up on the “power” but recharge it into a benevolent 
force. Some of the medical cannabis cultivators would like to get a better 
understanding of the mechanics and participate in medical research. But others, 
like Brendan, are concerned about corporate takeover, the standardisation of 
cannabis crops, and the exploitation of a benevolent plant for profit.  
                                                        
16 https://illegallyhealed.com/patient-success-stories/ 
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Not having an explanation, moreover, reinforces the nebulous status of cannabis 
as a non-human agent, with a quasi-sacred mission to bring health and restore 
sanity in a corrupt, materialist world. The very absence of rationally explained 
mechanisms of action has enabled self-taught activists like Liam. They can seize 
the opportunities opening up with rising demand for affordable cannabis 
medicines.  
Alongside the obvious financial gains, there are intangible social benefits from 
participation in emerging networks where product quality is celebrated (Potter 
2010). More difficult to gauge is the chance to display virtue, through altruistic 
acts of sharing.  
 
Doug says that two days prior to our interview he drove 15 miles to supply 
cannabis oil to someone he met online, not for profit on the sale, but to help a 
“guy who is in pain.” Turning people into healers is yet another aspect of green 
power. It makes Rachel feel good to help people and their families, especially 
“when you’re really, really afraid and the walls are red hot and the helicopter is 
flying overhead and it’s 37 degrees in the bloody tent”.  
 
Liam has been in prison for large commercial grow-operations and other 
offences. When he is talking about the opportunities of cannabis he refers to 
more than the medical needs of the 12-year-old girl he “is helping treating. She 
has been on the oil for 5 weeks and the change is amazing. From her having black 
eyes, yellow skin – she has a brain tumour – now the black eye has gone, the skin 
is back to pink, and she is now playing with her young brother and sister. If we 
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didn’t get the oil the doctors gave her 6 months to live, the tumour is golf ball 
sized. Now the oil is fighting the cancer, we think it’s going to change her life.”  
 
It has also changed Liam’s life, by allowing him to repair his fractured moral self 




There is still a lack of clear scientific understanding about when and how 
cannabis – and which constituent cannabinoids – does effectively treat particular 
medical conditions, and it may be that for some medical users effects are 
palliative rather than curative. Nevertheless, many people clearly perceive 
medical benefits – sometimes very strong benefits – from their cannabis use. 
Further, we acknowledge that our sample are both extreme and ‘ideal’ cases of 
medical cannabis growers, and that others claiming to grow or use cannabis for 
medical purposes may be less easily distinguished from recreational use or 
profit-oriented supply (cf. Reinarman et al, 2011; Hakkarainen et al. 2015; ; 
Sznitman 2017; Hakkarainen et al., in press). Nevertheless, the potential of 
medical cannabis growers to re-energise the UK drug policy debate, already 
reflected in the inching acknowledgement of medical benefits by the Medicines 
and Healthcare Products Regulatory Agency decision in 2016 to consider CBD 
products as medicines, is completely disproportionate to their number.  By 
tracking the journey and motivation of medical cultivator activists we have 
argued that their anomalous position as non-hedonist users and not-for profit 
suppliers has broken the frame on which cannabis prohibition is based. The 
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benefits they attest to gaining from cannabis redefines it as medicine, despite 
opposition from orthodox medicine and the criminal justice system. Medical 
cannabis growers are not criminal perpetrators but victims, a role captured by 
the campaign name “End our Pain”. In the US the redefinition of voters as victims 
of crime in the 1970s transformed the political landscape and the relationship 
between citizens and state (Simon, 2007). But whereas policy makers called for 
more state, meaning police, courts and prisons, the impetus behind medical 
cannabis is for a dismantling of the punitive system and a freedom from the 
state. There is no breakdown into anarchy, but a call for a regulated system as 
proposed by the UKCSC.  
 
Pro-cannabis regulation discussions continue to be dominated by aggregate 
benefits expressed in terms of criminal justice savings and tax revenues 
(McGinty et al., 2016). But in the medical cannabis user there is a human subject 
to identify and sympathise with. As these calls are becoming increasingly self-
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